6927 related articles for article (PubMed ID: 12003637)
1. Characterization of the murine 5T4 oncofoetal antigen: a target for immunotherapy in cancer.
Woods AM; Wang WW; Shaw DM; Ward CM; Carroll MW; Rees BR; Stern PL
Biochem J; 2002 Aug; 366(Pt 1):353-65. PubMed ID: 12003637
[TBL] [Abstract][Full Text] [Related]
2. Isolation of a high affinity scFv from a monoclonal antibody recognising the oncofoetal antigen 5T4.
Shaw DM; Embleton MJ; Westwater C; Ryan MG; Myers KA; Kingsman SM; Carroll MW; Stern PL
Biochim Biophys Acta; 2000 Dec; 1524(2-3):238-46. PubMed ID: 11113573
[TBL] [Abstract][Full Text] [Related]
3. Attenuated recombinant vaccinia virus expressing oncofetal antigen (tumor-associated antigen) 5T4 induces active therapy of established tumors.
Mulryan K; Ryan MG; Myers KA; Shaw D; Wang W; Kingsman SM; Stern PL; Carroll MW
Mol Cancer Ther; 2002 Oct; 1(12):1129-37. PubMed ID: 12481437
[TBL] [Abstract][Full Text] [Related]
4. Metastasis-associated 5T4 oncofoetal antigen is concentrated at microvillus projections of the plasma membrane.
Carsberg CJ; Myers KA; Evans GS; Allen TD; Stern PL
J Cell Sci; 1995 Aug; 108 ( Pt 8)():2905-16. PubMed ID: 7593330
[TBL] [Abstract][Full Text] [Related]
5. Metastasis-associated 5T4 antigen disrupts cell-cell contacts and induces cellular motility in epithelial cells.
Carsberg CJ; Myers KA; Stern PL
Int J Cancer; 1996 Sep; 68(1):84-92. PubMed ID: 8895545
[TBL] [Abstract][Full Text] [Related]
6. Glycosylation and epitope mapping of the 5T4 glycoprotein oncofoetal antigen.
Shaw DM; Woods AM; Myers KA; Westwater C; Rahi-Saund V; Davies MJ; Renouf DV; Hounsell EF; Stern PL
Biochem J; 2002 Apr; 363(Pt 1):137-45. PubMed ID: 11903056
[TBL] [Abstract][Full Text] [Related]
7. 5T4 oncofoetal antigen: an attractive target for immune intervention in cancer.
Stern PL; Harrop R
Cancer Immunol Immunother; 2017 Apr; 66(4):415-426. PubMed ID: 27757559
[TBL] [Abstract][Full Text] [Related]
8. 5T4 oncofoetal glycoprotein: an old target for a novel prostate cancer immunotherapy.
Cappuccini F; Pollock E; Stribbling S; Hill AVS; Redchenko I
Oncotarget; 2017 Jul; 8(29):47474-47489. PubMed ID: 28537896
[TBL] [Abstract][Full Text] [Related]
9. The 5T4 oncofoetal antigen is an early differentiation marker of mouse ES cells and its absence is a useful means to assess pluripotency.
Ward CM; Barrow K; Woods AM; Stern PL
J Cell Sci; 2003 Nov; 116(Pt 22):4533-42. PubMed ID: 14576347
[TBL] [Abstract][Full Text] [Related]
10. Expression of the 5T4 oncofoetal antigen in renal cell carcinoma: a potential target for T-cell-based immunotherapy.
Griffiths RW; Gilham DE; Dangoor A; Ramani V; Clarke NW; Stern PL; Hawkins RE
Br J Cancer; 2005 Sep; 93(6):670-7. PubMed ID: 16222313
[TBL] [Abstract][Full Text] [Related]
11. Murine responses to recombinant MVA versus ALVAC vaccines against tumor-associated antigens, gp100 and 5T4.
Hanwell DG; McNeil B; Visan L; Rodrigues L; Dunn P; Shewen PE; Macallum GE; Turner PV; Vogel TU
J Immunother; 2013 May; 36(4):238-47. PubMed ID: 23603858
[TBL] [Abstract][Full Text] [Related]
12. Understanding and exploiting 5T4 oncofoetal glycoprotein expression.
Stern PL; Brazzatti J; Sawan S; McGinn OJ
Semin Cancer Biol; 2014 Dec; 29():13-20. PubMed ID: 25066861
[TBL] [Abstract][Full Text] [Related]
13. Overexpression and potential targeting of the oncofoetal antigen 5T4 in malignant pleural mesothelioma.
Al-Taei S; Salimu J; Lester JF; Linnane S; Goonewardena M; Harrop R; Mason MD; Tabi Z
Lung Cancer; 2012 Aug; 77(2):312-8. PubMed ID: 22498111
[TBL] [Abstract][Full Text] [Related]
14. Regulation of autologous immunity to the mouse 5T4 oncofoetal antigen: implications for immunotherapy.
Castro FV; Al-Muftah M; Mulryan K; Jiang HR; Drijfhout JW; Ali S; Rutkowski AJ; Kalaitsidou M; Gilham DE; Stern PL
Cancer Immunol Immunother; 2012 Jul; 61(7):1005-18. PubMed ID: 22127365
[TBL] [Abstract][Full Text] [Related]
15. E-cadherin inhibits cell surface localization of the pro-migratory 5T4 oncofetal antigen in mouse embryonic stem cells.
Spencer HL; Eastham AM; Merry CL; Southgate TD; Perez-Campo F; Soncin F; Ritson S; Kemler R; Stern PL; Ward CM
Mol Biol Cell; 2007 Aug; 18(8):2838-51. PubMed ID: 17507657
[TBL] [Abstract][Full Text] [Related]
16. Embryonic expression of murine 5T4 oncofoetal antigen is associated with morphogenetic events at implantation and in developing epithelia.
Barrow KM; Ward CM; Rutter J; Ali S; Stern PL
Dev Dyn; 2005 Aug; 233(4):1535-45. PubMed ID: 15977177
[TBL] [Abstract][Full Text] [Related]
17. Isolation of a cDNA encoding 5T4 oncofetal trophoblast glycoprotein. An antigen associated with metastasis contains leucine-rich repeats.
Myers KA; Rahi-Saund V; Davison MD; Young JA; Cheater AJ; Stern PL
J Biol Chem; 1994 Mar; 269(12):9319-24. PubMed ID: 8132670
[TBL] [Abstract][Full Text] [Related]
18. The pattern of expression of the 5T4 oncofoetal antigen on normal, dysplastic and malignant oral mucosa.
Ali A; Langdon J; Stern P; Partridge M
Oral Oncol; 2001 Jan; 37(1):57-64. PubMed ID: 11120484
[TBL] [Abstract][Full Text] [Related]
19. Therapy of human non-small-cell lung carcinoma using antibody targeting of a modified superantigen.
Forsberg G; Ohlsson L; Brodin T; Björk P; Lando PA; Shaw D; Stern PL; Dohlsten M
Br J Cancer; 2001 Jul; 85(1):129-36. PubMed ID: 11437414
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies specific for human tumor-associated antigen 90K/Mac-2 binding protein: tools to examine protein conformation and function.
Laferté S; Loh LC; Keeler V
J Cell Biochem; 2000 Apr; 77(4):540-59. PubMed ID: 10771511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
